NZVC

oVRcome ·25 May 2021·1 outlet

oVRcome was cleared to run a clinical trial

The Christchurch company got the green light for a clinical trial of its smartphone VR exposure therapy. Adam Hutchinson started oVRcome as a lockdown side project and worked with clinical psychologists to put exposure therapy for phobias on a phone.

We backed oVRcome because effective exposure therapy is hard to access and expensive to deliver, and a phone puts it within reach. Demand for accessible mental health treatment far outstrips the supply of clinicians, and a trial is what separates a self-guided app from an evidence-based one.

Company
oVRcome, www.ovrcome.io
First reported
25 May 2021
Outlets
Scoop

Who covered it

Headlines and links belong to the publications that wrote them. Everything above this line is ours.

Back to the clippings file